AU3430699A - Butenolide derivatives as anti-cancer agents - Google Patents
Butenolide derivatives as anti-cancer agentsInfo
- Publication number
- AU3430699A AU3430699A AU34306/99A AU3430699A AU3430699A AU 3430699 A AU3430699 A AU 3430699A AU 34306/99 A AU34306/99 A AU 34306/99A AU 3430699 A AU3430699 A AU 3430699A AU 3430699 A AU3430699 A AU 3430699A
- Authority
- AU
- Australia
- Prior art keywords
- cancer agents
- butenolide
- derivatives
- butenolide derivatives
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/66—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9807773.8A GB9807773D0 (en) | 1998-04-08 | 1998-04-08 | Anti-cancer agent |
| GB9807773 | 1998-04-08 | ||
| GB9813674 | 1998-06-24 | ||
| GBGB9813674.0A GB9813674D0 (en) | 1998-06-24 | 1998-06-24 | Anti-cancer agent |
| PCT/GB1999/001074 WO1999052888A1 (en) | 1998-04-08 | 1999-04-08 | Butenolide derivatives as anti-cancer agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3430699A true AU3430699A (en) | 1999-11-01 |
Family
ID=26313459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU34306/99A Abandoned AU3430699A (en) | 1998-04-08 | 1999-04-08 | Butenolide derivatives as anti-cancer agents |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3430699A (en) |
| WO (1) | WO1999052888A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002002533A1 (en) | 2000-07-05 | 2002-01-10 | Yamanouchi Pharmaceutical Co., Ltd. | Propane-1,3-dione derivatives |
| GB0312360D0 (en) * | 2003-05-30 | 2003-07-02 | Univ Aston | Novel 4-amino-2(5H)-furanones |
| WO2005026141A2 (en) * | 2003-09-17 | 2005-03-24 | Warner-Lambert Company Llc | Process for preparation of substituted butenolides via palladium-free etherification and amination of masked mucohalic acids |
| WO2005118556A1 (en) | 2004-06-04 | 2005-12-15 | Astellas Pharma Inc. | Propane-1,3-dione derivative or its salt |
| PT1864976E (en) | 2005-03-31 | 2013-01-04 | Astellas Pharma Inc | Propane-1,3-dion derivative or salt thereof |
| CA2689707A1 (en) * | 2009-11-16 | 2011-05-16 | Jean-Simon Diallo | Identification of the novel small molecule viral sensitizer vse1 using high-throughput screening |
| WO2016119052A1 (en) | 2015-01-26 | 2016-08-04 | Ottawa Hospital Research Institute | Compositions and methods for enhancing oncolytic virus efficacy |
| CN109320505B (en) * | 2018-11-08 | 2022-08-02 | 海利尔药业集团股份有限公司 | Preparation and application of halogenated butenolide compound with insecticidal activity |
| CN111196791B (en) * | 2020-01-20 | 2022-03-08 | 中山大学 | Chiral gamma-butyrolactone derivative and synthesis method and application thereof |
| CN112321402B (en) * | 2020-11-10 | 2022-11-29 | 西安石油大学 | Method for preparing 2-hydroxyethyl phenyl ketone by coupling two components |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ271833A (en) * | 1993-08-19 | 1997-08-22 | Warner Lambert Co | Substituted 2(5h)-furanone (or thiophenone or pyrrolone) derivatives |
| AU6388896A (en) * | 1995-07-06 | 1997-02-05 | Warner-Lambert Company | Butenolide endothelin antagonists |
-
1999
- 1999-04-08 AU AU34306/99A patent/AU3430699A/en not_active Abandoned
- 1999-04-08 WO PCT/GB1999/001074 patent/WO1999052888A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999052888A1 (en) | 1999-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL146100A0 (en) | 4,5,6,7-tetrahydroindazole derivatives as antitumor agents | |
| AU2001252463A1 (en) | Thiophene derivatives useful as anticancer agents | |
| AU6314900A (en) | Biarylurea derivatives | |
| AU6714700A (en) | Cyclopropylindole derivatives | |
| AU2001236678A1 (en) | Adamantyl derivatives as anti-cancer agents | |
| AU4548899A (en) | Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents | |
| AU1379900A (en) | Novel substituted phenyloxazolidone derivatives | |
| AU8414098A (en) | Noscapine derivatives, useful as anticancer agents | |
| AU3430699A (en) | Butenolide derivatives as anti-cancer agents | |
| AU5762099A (en) | The preparation of (n)-substituted-hydroxycycloalkylamine derivatives | |
| AU3167699A (en) | Vitamin d derivatives substituted at the 2beta-position | |
| AU2656799A (en) | Metal-thiols as imminomodulating agents | |
| AU4435199A (en) | Isoflavone derivatives | |
| AU2830800A (en) | Chroman derivatives | |
| AU6228299A (en) | 2-substituted-d-homooxasteroid derivatives | |
| AU6108499A (en) | Pyrrolopyrrolone derivatives as antiviral agents | |
| AU2199201A (en) | Anthracene derivatives as anti-cancer agents | |
| AU2640999A (en) | 1-azaindolizine derivatives | |
| AU6262300A (en) | Indolinylamide derivatives | |
| AU1558300A (en) | 1-cycloalkylpyrazoyl-benzoyl derivatives | |
| AU1347701A (en) | Oxetanone derivatives | |
| AU4141099A (en) | Pyrazolyldioxothiochromanoyl derivatives | |
| AU2894099A (en) | Phenanthrofuran derivatives | |
| AU5239899A (en) | Amidophosphate derivatives | |
| AU2641099A (en) | Imidazoquinazoline derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |